The PAAG regimen significantly improved PFS and response rates in metastatic pancreatic cancer compared to chemotherapy alone ...
Racial and ethnic disparities in pancreatic cancer treatment and survival persist, with minority groups experiencing lower ...
SAN FRANCISCO -- Almost 80% of patients with heavily pretreated advanced/metastatic pancreatic cancer achieved disease ...
It's the question believers have asked for centuries when wars threaten nations, storms ravage cities and diseases strike loved ones: "Why, oh God, why?" ...
Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...
To kick off 2026, PanCAN’s Volunteer Advisory Council shares a warm message of advice and encouragement with PanCAN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results